SCHEMBL203793

SCHEMBL203793

CC1(C)CC2(CC(C)(C)c3ccc(Oc4ccc(N)cc4)cc32)c2cc(Oc3ccc(N)cc3)ccc21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.47
RXRA P19793 1/20 0.47
RXRB P28702 1/20 0.47
RXRG P48443 1/20 0.47
ALDH1A1 P00352 8/20 0.46
MAPT P10636 5/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
MITF O75030 1/20 0.46
GAA P10253 1/20 0.46
GFER P55789 1/20 0.46
NLRP1 Q9C000 1/20 0.46
NOD2 Q9HC29 1/20 0.46
TDP1 Q9NUW8 4/20 0.45
CYP3A4 P08684 2/20 0.45
TSHR P16473 1/20 0.45
TEAD4 Q15561 1/20 0.43
POLB P06746 1/20 0.42
MAPK1 P28482 3/20 0.41
MAOA P21397 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29608602 1.00 SMN1; SMN2 (0.47) SMN1; SMN2RXRARXRBRXRGALDH1A1
SCHEMBL16248010 0.95 SMN1; SMN2 (0.49) SMN1; SMN2RXRARXRBRXRGALDH1A1
SCHEMBL29521690 0.86 MAOB (0.49) SMN1; SMN2RXRARXRBRXRGALDH1A1
SCHEMBL204909 0.86 MAOB (0.49) SMN1; SMN2RXRARXRBRXRGALDH1A1
SCHEMBL8013533 0.86 TEAD4 (0.44) SMN1; SMN2RXRARXRBRXRGALDH1A1
SCHEMBL24684596 0.83 RXRA (0.43) SMN1; SMN2RXRARXRBRXRGALDH1A1
SCHEMBL31534579 0.83 RXRA (0.43) SMN1; SMN2RXRARXRBRXRGALDH1A1
SCHEMBL10650452 0.83 RXRA (0.43) SMN1; SMN2RXRARXRBRXRGALDH1A1
Hydrochloric Acid SCHEMBL10653222 0.82 RXRA (0.43) SMN1; SMN2RXRARXRBRXRGALDH1A1
SCHEMBL27092144 0.82 ALDH1A1 (0.54) SMN1; SMN2RXRARXRBRXRGALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 155 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260071028-A1 BINDER FOR ENERGY STORAGE DEVICE, ELECTRODE FOR ENERGY STORAGE DEVICE, ENERGY STORAGE DEVICE, POLYMER COMPOSITE, AND PRODUCTION METHOD OF BINDER FOR ENERGY STORAGE DEVICE UBE CORP (JP) 2026-03-12 US disclosed
US-20260071029-A1 POLYIMIDE PRECURSOR COMPOSITION, POLYIMIDE FILM AND POLYIMIDE/SUBSTRATE LAMINATE UBE CORP (JP) 2026-03-12 US disclosed
EP-4674891-A1 POLYIMIDE POWDER FOR MOLDED BODY, AND POLYIMIDE MOLDED BODY UBE Corporation (JP) 2026-01-07 EP disclosed
US-20250346020-A1 LAMINATE AND DISPLAY KANEKA CORPORATION (JP) 2025-11-13 US disclosed
US-20250243324-A1 POLYIMIDE PRECURSOR COMPOSITION AND METHOD FOR PRODUCING THE SAME UBE CORPORATION (JP) 2025-07-31 US disclosed
US-20250215153-A1 POLYIMIDE PRECURSOR COMPOSITION FOR FLEXIBLE WIRING BOARDS, POLYIMIDE FILM, AND POLYIMIDE METAL LAMINATE UBE CORPORATION (JP) 2025-07-03 US disclosed
US-20250171590-A1 POLYIMIDE PRECURSOR FOR DISPLAY SUBSTRATE, POLYIMIDE FILM FOR DISPLAY SUBSTRATE, AND DISPLAY SUBSTRATE UBE CORPORATION (JP) 2025-05-29 US disclosed
US-20250163218-A1 POLYIMIDE PRECURSOR FOR DISPLAY SUBSTRATE, POLYIMIDE FILM FOR DISPLAY SUBSTRATE, AND DISPLAY SUBSTRATE UBE CORPORATION (JP) 2025-05-22 US disclosed
WO-2025100308-A1 RESIN COMPOSITION, CURED PRODUCT, AND DISPLAY DEVICE OR SEMICONDUCTOR DEVICE 東レ株式会社 2025-05-15 WO disclosed
WO-2025079540-A1 POLYIMIDE PRECURSOR COMPOSITION, POLYIMIDE FILM, MULTILAYER OBJECT, AND ELECTRONIC DEVICE SUBSTRATE INCLUDING THESE UBE株式会社 2025-04-17 WO disclosed
EP-1148078-A1 POLYIMIDE CONTAINING CROSSLINKABLE GROUP AND PROCESS FOR PRODUCING THE SAME Mitsui Chemicals, Inc. (JP) 2001-10-24 EP disclosed
US-6203922-B1 GLASSY THERMOPLASTIC RESINS WITH GLASS TRANSITION TEMPERATURE THE REGENTS OF THE UNIVERSITY OF MICHIGAN 2001-03-20 US disclosed
US-6103860-A LOW DIELECTRIC CONSTANT, EXCELLENT TRANSPARENCY, LOW HYGROSCOPICITY AND EXCELLENT PROCESSABILITY; SUBSTRATE FOR AN OPTICAL DISK, A PICK-UP LENS, A PLASTIC SUBSTRATE FOR A LIQUID CELL AND A PRISM MITSUI CHEMICALS, INC. (JP) 2000-08-15 US disclosed
US-6080833-A BIS(HYDROXYALKOXYLATED) 1,1'-SPIROBIINDAN POLYCARBONATES AND POLYESTERS POLYMERS AND CURABLE COMPOUNDS SUCH AS BIS(ACRYLATED ALKOXY)SPIROBIINDANS; ALSO POLYAMIDES AND POLYIMIDES CONTAINING SPIROBIINDAN GROUPS MITSUI CHEMICALS, INC. (JP) 2000-06-27 US disclosed
US-5990261-A Organic optical component MITSUI CHEMICALS, INC. (JP) 1999-11-23 US disclosed
WO-1999021910-A1 OPTICALLY ACTIVE POLY(ARYL)ETHERS CONTAINING OPTICALLY PURE SPIROBIINDANE OR INDANE MOIETIES MOLECULAR OPTOELECTRONICS CORPORATION (US) 1999-05-06 WO disclosed
US-5856422-A Optically active poly(aryl)ethers containing optically pure spirobindane and indane moieties MOLECULAR OPTOELECTRONICS CORPORATION (US) 1999-01-05 US disclosed
EP-0826717-A1 An organic optical component MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1998-03-04 EP disclosed
EP-0822545-A2 Optical component and spirobiindan polymer therefor MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1998-02-04 EP disclosed
US-4734482-A Polyimide from ether diamine having the indane structure and high-temperature adhesive of polyimide MITSUI TOATSU CHEMICALS, INC. (JP) 1988-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260071029-A1 POLYIMIDE PRECURSOR COMPOSITION, POLYIMIDE FILM AND POLYIMIDE/SUBSTRATE LAMINATE SMC1A, F11, F12 SMN1; SMN2 520/4885RXRA 3136/4885RXRB 3059/4885
US-20260071028-A1 BINDER FOR ENERGY STORAGE DEVICE, ELECTRODE FOR ENERGY STORAGE DEVICE, ENERGY STORAGE DEVICE, POLYMER COMPOSITE, AND PRODUCTION METHOD OF BINDER FOR ENERGY STORAGE DEVICE TBCA, TBCD, TBCB SMN1; SMN2 3852/4885RXRA 3995/4885RXRB 3656/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.